MOUNTAIN VIEW, Calif., Nov. 16 /PRNewswire-FirstCall/ -- Hansen Medical, Inc. (Nasdaq: HNSN - News) announced today the initial public offering of 6,250,000 shares of common stock at a price of $12.00 per share. Hansen Medical’s common stock is expected to begin trading on the NASDAQ Global Market under the trading symbol HNSN on Thursday, November 16, 2006. All of the shares in the offering are being offered by Hansen Medical.
The underwriters of the offering will be Morgan Stanley & Co. Incorporated and J.P. Morgan Securities Inc. as joint bookrunners, and Thomas Weisel Partners LLC and Leerink Swann & Co., Inc. as co-managers. Hansen Medical has granted the underwriters a 30-day option to purchase up to an additional 937,500 shares to cover over-allotments, if any.
A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on November 15, 2006. This offering is being made by means of written prospectus. Copies of the final prospectus relating to the offering, when available, may be obtained from Morgan Stanley & Co. Incorporated’s prospectus department at 180 Varick, New York, NY 10014, by telephone at (866) 718-1649 or by emailing prospectus@morganstanley.com, or from J.P. Morgan Securities Inc.'s prospectus department at 4 Chase Metrotech Center, Floor L2, Brooklyn, NY 11245 or by phone at (718) 242-8002.
This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor will there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Hansen Medical, Inc.
Hansen Medical, based in Mountain View, California, was founded in 2002 to develop products and technology using robotics for the accurate positioning, manipulation and stable control of catheters and catheter-based technologies. The Sensei(TM) Robotic Catheter System and disposable Artisan(TM) Control Catheter are currently under review for FDA clearance to guide catheters for mapping the heart anatomy.
Media Contact: Investor Contacts: Amy Cook Steven Van Dick 925.552.7893 650.404.5820 amy_cook@hansenmedical.com steve_vandick@hansenmedical.com At the Financial Relations Board: Kathy Waller 312.640.6696
Source: Hansen Medical, Inc.
